0001601983-16-000002.txt : 20160909 0001601983-16-000002.hdr.sgml : 20160909 20160909131456 ACCESSION NUMBER: 0001601983-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160909 DATE AS OF CHANGE: 20160909 EFFECTIVENESS DATE: 20160909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHRONO THERAPEUTICS INC. CENTRAL INDEX KEY: 0001601983 IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-270385 FILM NUMBER: 161878472 BUSINESS ADDRESS: STREET 1: 3953 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 362-7823 MAIL ADDRESS: STREET 1: 3953 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 D 1 primary_doc.xml X0707 D LIVE 0001601983 CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 (510) 362-7823 CALIFORNIA DiPierro Ventures, Inc. None Corporation true ALAN LEVY, PH.D. C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Executive Officer Director ANTHONY RIMAC C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Executive Officer JAMES W. YOUNG C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Director WENDE HUTTON C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Director TIM KILGALLON C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Director GUY DIPIERRO C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Director AIDAN KING C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Director STEVEN JAMES C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Director ELIZABETH ROCKETT C/O CHRONO THERAPEUTICS INC. 3953 POINT EDEN WAY HAYWARD CA CALIFORNIA 94545 Director Other Health Care Decline to Disclose 06b false 2016-08-26 false true false 0 47607004 37606945 10000059 Shares of Series B Preferred Stock and shares of Common Stock issuable upon conversion of the shares of Series B Preferred Stock. false 22 0 true 0 true 0 true false CHRONO THERAPEUTICS INC. /s/ Anthony M. Rimac ANTHONY M. RIMAC CHIEF FINANCIAL OFFICER 2016-09-09